Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

229 Press Releases
DateTitleCompany
18 Dec 13 All Wales Medicines Strategy Group recommends Onglyza® (saxagliptin) for use in triple therapy for type 2 diabetes patients Bristol-Myers Squibb and AstraZeneca,
Published by
Packer Forbes Communications
18 Dec 13 Computer-controlled table could direct radiotherapy to tumours The Institute of Cancer Research
18 Dec 13 ABPI response to GSK announcement regarding changes to its global sales and marketing practice ABPI
18 Dec 13 UKCPA welcomes Scottish government’s vision for pharmaceutical care UKCPA
18 Dec 13 Centro Ricerche Cliniche di Verona Receives First Ever EUCROF Early Phase Unit Quality Mark CROMSOURCE
16 Dec 13 All Wales Medicines Strategy Group recommends Onglyza® (saxagliptin) for use in triple therapy for type 2 diabetes patients Bristol-Myers Squibb and AstraZeneca,
Published by
Packer Forbes Communications
16 Dec 13 Recipharm subsidiary files infectious disease drug application in European markets RPH Pharmaceuticals AB,
Published by
DeFacto Communications
16 Dec 13 AstraZeneca announces top-line results from phase III monotherapy study of lesinurad in gout patients AstraZeneca
13 Dec 13 GILEAD ANNOUNCES INTERIM PHASE 2 RESULTS FOR GS-9973 IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA Gilead Sciences, Inc,
Published by
Gilead Sciences
13 Dec 13 GILEAD ANNOUNCES PIVOTAL PHASE 2 DATA FOR IDELALISIB IN REFRACTORY INDOLENT NON-HODGKIN’S LYMPHOMA Gilead Sciences, Inc.,
Published by
Gilead Sciences
12 Dec 13 CPhI Japan 2014: Japanese market to continue to dominate global pharma CPhI,
Published by
DeFacto Communications
12 Dec 13 Bridgepoint Development Capital to acquire Quotient Clinical Quotient Clinical,
Published by
Bridgepoint
12 Dec 13 Pharma Companies & Doctors need to widen the gap of meaningful dialogue in scientific & medical communications. Ethics in Medical Profession is key to sustainable growth & innovation – Satya Brahma pharmaleaders,
Published by
http://breakfastnews.tv/
12 Dec 13 US & Europe Orphan Drug Market: 817 Orphan Designated Drug in Clinical Development Phase in US & Europe PNS Pharma
11 Dec 13 Senior-Level Pharmaceutical Experts, Keynotes from Pharma VP, Trends & Analytics Guru- All at ‘Super Bowl’ of Pharma Biotech Conferences Pharma Market Research Conference
11 Dec 13 Pharmaceutical, Biotechnology, Healthcare Experts to Converge at Crucial Event in 2014 Pharma CI Conference
11 Dec 13 Tecan’s Cavro® Air Displacement Pipettor proves ideal for new microbiology application Tecan
11 Dec 13 Lundbeck and Otsuka to co-develop a vaccine, Lu AF20513, their third collaborative development project to tackle Alzheimer’s disease Lundbeck
10 Dec 13 Almac wins Laboratory Team of the Year at The Irish Laboratory Awards 2013 Almac,
Published by
De Facto Communications
09 Dec 13 GA101 (obinutuzumab) becomes first and only treatment to demonstrate superior efficacy over MabThera® (rituximab) in a first-line Phase III CLL study Roche
06 Dec 13 Physician Workshop for Biomedical Testing The Great Plains Laboratory, Inc.
03 Dec 13 KMR Group Announces Best Places For Clinical Research KMR Group, Inc.
03 Dec 13 Exco InTouch to share insights into mHealth solutions for clinical research at mHealth Summit Exco InTouch,
Published by
DeFacto Communications
02 Dec 13 New Drugs for Atrial Fibrillation Represent Choices for Clinicians, Opportunities for Generics Symporia Bioscience
02 Dec 13 Rise of generics and patent expirations sees CPhI and P-MEC India 2013 expand CPhI,
Published by
De Facto Communications
28 Nov 13 HORIBA launches Online Clinical Diagnostics Information Resource HORIBA UK Ltd,
Published by
Alto Marketing Limited
28 Nov 13 MONSTER MANOR APP SET TO BE A GAME CHANGER IN THE MANAGEMENT OF DIABETES FOR THE SMARTER iGENERATION Sanofi,
Published by
Reynolds-MacKenzie
28 Nov 13 Talentmark Supports its US client base with a New Office in Boston Talentmark
27 Nov 13 Building a case of precision pipetting with Tecan’s Air LiHa Tecan
26 Nov 13 Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer Almac Group Ltd,
Published by
DeFacto Communications
Advertising